AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹170 Cr | ₹197 Cr | ₹164 Cr | ₹133 Cr | ₹152 Cr |
What is the latest Revenue of AMBALAL SARABHAI ENTERPRISES ?
Year | Revenue |
---|---|
Mar2024 | ₹170 Cr |
Mar2023 | ₹197 Cr |
Mar2022 | ₹164 Cr |
Mar2021 | ₹133 Cr |
Mar2020 | ₹152 Cr |
How is Revenue of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹170 Cr | -13.45 | |
Mar2023 | ₹197 Cr | 20.23 | |
Mar2022 | ₹164 Cr | 22.58 | |
Mar2021 | ₹133 Cr | -12.10 | |
Mar2020 | ₹152 Cr | - |
Compare Revenue of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹281.5 Cr | 3.8% | 2.2% | -18.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,588.0 Cr | -7.3% | 1.1% | 15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,711.0 Cr | -3.5% | 12.9% | 53.4% | Stock Analytics | |
CIPLA | ₹122,115.0 Cr | 0.1% | 9.2% | 6.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,589.0 Cr | -1% | 0.2% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,746.6 Cr | 3.1% | 9.8% | -7.6% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | 3.8% |
2.2% |
-18.4% |
SENSEX | 2% |
9.4% |
11.6% |
You may also like the below Video Courses